The Systematic COronary Risk Evaluation (SCORE) in a large UK population: 10-year follow-up in the EPIC-Norfolk prospective population study

European Journal of Preventive Cardiology

Volumn 22, Issue 1, 2015, Pages 119-126

  Jørstad, Harald Thune ^a   Colkesen, Ersen B ^b   Minneboo, Madelon ^a   Peters, Ron J G ^a   Boekholdt, S Matthijs ^a   Tijssen, Jan G P ^a   Wareham, Nicholas J ^c   Khaw, Kay Tee ^d  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b ST ANTONIUS HOSPITAL   (Netherlands)

^c MRC EPIDEMIOLOGY UNIT   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Algorithms; Cardiovascular diseases; Risk factors

Indexed keywords

ADULT; AGED; ALGORITHM; AORTA ANEURYSM; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; CORONARY RISK; DEATH; FEMALE; FOLLOW UP; HEART FAILURE; HIGH RISK POPULATION; HUMAN; ISCHEMIC HEART DISEASE; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POPULATION RESEARCH; PROSPECTIVE STUDY; SYSTEMATIC CORONARY RISK EVALUATION; UNITED KINGDOM; CAUSE OF DEATH; COMPARATIVE STUDY; CORONARY DISEASE; ENGLAND; KAPLAN MEIER METHOD; MIDDLE AGED; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; TIME FACTOR;

ADULT; AGED; ALGORITHMS; CAUSE OF DEATH; CORONARY DISEASE; ENGLAND; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS;

EID: 84918496292     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1177/2047487313503609     Document Type: Article

References (19)

1. Perk J, De Backer G, Gohlke H, et al. European guidelines on cardiovascular disease prevention in clinical practice: The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J 2012; 33(13): 1635-1701.
2. Conroy RM, Pyörälä K, Fitzgerald AP, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: The SCORE project. Eur Heart J 2003; 24: 987-1003.
3. European Society of Cardiology (ESC). HeartScore. http://www.heartscore.org/ (2007, accessed 5 June 2012)
4. World Health Organization. Global Health Observatory Data Repository. http://apps.who.int/ghodata/ (2011, accessed 5 June 2012)
5. Day N, Oakes S, Luben R, et al. EPIC-Norfolk: Study design and characteristics of the cohort. European Prospective Investigation of Cancer. Br J Cancer 1999; 80(Suppl. 1): 95-103.
6. Friedewald WT, Levy RI and Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
7. Bennett N, Dodd T, Flatley F, et al. Health survey for England 1993. London: HMSO, 1995.
8. Boekholdt SM, Peters RJG, Day NE, et al. Macrophage migration inhibitory factor and the risk of myocardial infarction or death due to coronary artery disease in adults without prior myocardial infarction or stroke: The EPIC-Norfolk prospective population study. Am J Med 2004; 117: 390-397.
9. Langsted A, Freiberg JJ and Nordestgaard BG. Fasting and nonfasting lipid levels: Influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction. Circulation 2008; 118: 2047-2056.
10. Levi F, Lucchini F, Negri E, et al. Trends in mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world. Heart 2002; 88: 119-124.
11. Hardoon SL, Whincup PH, Petersen I, et al. Trends in longer-term survival following an acute myocardial infarction and prescribing of evidenced-based medications in primary care in the UK from 1991: A longitudinal population-based study. J Epidemiol Community Health 2011; 65: 770-774.
12. Unal B, Critchley JA and Capewell S. Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000. Circulation 2004; 109: 1101-1107.
13. Capewell S and O'Flaherty M. Rapid mortality falls after risk-factor changes in populations. Lancet 2011; 378: 752-753.
14. Van Dis I, Kromhout D, Geleijnse JM, et al. Evaluation of cardiovascular risk predicted by different SCORE equations: The Netherlands as an example. Eur J Cardiovasc Prev Rehabil 2010; 17: 244-249.
15. De Bacquer D and De Backer G. Predictive ability of the SCORE Belgium risk chart for cardiovascular mortality. Int J Cardiol 2010; 143: 385-390.
16. Tunstall-Pedoe H. Cardiovascular risk and risk scores: ASSIGN, Framingham, QRISK and others: How to choose. Heart 2011; 97: 442-444.
17. Hippisley-Cox J, Coupland C, Vinogradova Y, et al. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: Prospective open cohort study. BMJ 2007; 335: 136.
18. Hippisley-Cox J, Coupland C, Vinogradova Y, et al. Predicting cardiovascular risk in England and Wales: Prospective derivation and validation of QRISK2. BMJ 2008; 336: 1475-1482.
19. Scarborough P, Bhatnagar P, Wickramasinghe K, et al. Coronary Heart Disease Statistics, 2010 edition. Department of Public Health, University of Oxford: British Heart Foundation Health Promotion Research Group, 2010.